Analyst upgrades: COR, RBS and TWP

Filed under: Analyst reports, Analyst upgrades and downgrades

MOST NOTEWORTHY:

• Rodman & Renshaw upgraded Cortex Pharma (AMEX:COR) to Market Perform from Underperform citing the company's progress towards renewing its pipeline and notes that results from two proof-of-concept studies assessing acute administration of COR's lead AMPAKINE molecule are expected in the coming months.
  


• Citigroup upgraded shares of Royal Bank of Scotland (NYSE:RBS) to Buy from Hold on valuation following the recent weakness, as they believe the sell-off has been excessive.
  


• Suntrust raised Trex (NYSE:TWP) to Buy from Neutral based on management's turnaround efforts, expectations for increased market share in composite decking, and valuation, among other reasons.

• Friedman Billings upgraded Hot Topic (NASDAQ:HOTT) to Outperform from Market Perform.
  


• Lehman raised UAL Corp (NASDAQ:UAUA) and Northwest Airlines (NWA) to Overweight from Equal Weight.
  


• Goldman added Eli Lilly (NYSE:LLY) to its Conviction Buy List.

Permalink | Email this | Comments

<map name="google_ad_map_145-1216537"><area href="http://imageads.googleadservices.com/pagead/imgclick/145-1216537?pos=0" shape="rect" coords="1,2,367,28" /><area href="http://services.google.com/feedback/abg" shape="rect" coords="384,10,453,23" /></map>